Associate Professor, Oncologic Sciences, USF-Morsani
Oncology
Dr. Martine Extermann, MD
|
|
Give Review
Martine Extermann, MD is an expert in the field of Oncology. Dr. Martine Extermann is also published. She has 81 publications published. The lastest publication: "Relationship between cleaved L-selectin levels and the outcome of acute myeloid leukemia.' She is registered with Medicare and accepts Medicare payments.
Publications
- Phase 2 Study of Concurrent Cetuximab Plus Definitive Thoracic Radiation Therapy Followed by Consolidation Docetaxel Plus Cetuximab in Poor Prognosis or Elderly Patien...
- Screening tools for multidimensional health problems warranting a geriatric assessment in older Cancer patients: an update on SIOG recommendations.
- Potential drug interactions and chemotoxicity in older patients with Cancer receiving chemotherapy.
- Management of primary metastatic breast Cancer in elderly patients-An international comparison of oncogeriatric versus standard care.
- Health and personal resources in older patients with Cancer undergoing chemotherapy.
- Metabolic syndrome and Cancer: from bedside to bench and back.
- Pilot Study of Comprehensive Geriatric Assessment (CGA) in Allogeneic Transplant: CGA Captures a High Prevalence of Vulnerabilities in Older Transplant Recipients.
- Integrating a geriatric evaluation in the clinical setting.
- Metabolic syndrome, aging, and Cancer.
- Comprehensive geriatric assessment and its clinical impact in oncology.
- Senior adult oncology.
- Basic assessment of the older Cancer patient.
- Phase I/II trial of a COX-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung Cancer: radiation ...
- Can first cycle CBCs predict older patients at very low risk of neutropenia during further chemotherapy?
- Cancer in nonagenarians: profile, treatments and outcomes.
- Geriatric oncology: an overview of progresses and challenges.
- Hyperglycemia during chemotherapy for hematologic and solid tumors is correlated with increased toxicity.
- Larger questions about chemotherapy in older patients.
- Patterns of care and survival in Cancer patients with cognitive impairment.
- Multidimensional geriatric evaluation for older Cancer patients as a clinical and research tool.
- Fatigue and functional dependence in older Cancer patients.
- Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung Cancer (NSCLC) who are 70 years of age or older.
- Management of breast Cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology.
- Comprehensive geriatric assessment for older patients with Cancer.
- More thoughts on the reporting of adverse events in Cancer clinical trials.
- Interaction between comorbidity and Cancer.
- Individual differences in well-being in older breast Cancer survivors.
- Impact of breast Cancer survivorship on quality of life in older women.
- Treating advanced breast Cancer in the older woman.
- Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic Cell transplantation.
- The abbreviated comprehensive geriatric assessment (aCGA) for use in the older Cancer patient as a prescreen: scoring and interpretation.
- Geriatric assessment with focus on instrument selectivity for outcomes.
- Methotrexate-induced status epilepticus.
- Use of comprehensive geriatric assessment in older Cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG).
- Older patients, cognitive impairment, and Cancer: an increasingly frequent triad.
- Toward optimal screening strategies for older women. Costs, benefits, and harms of breast Cancer screening by age, biology, and health status.
- Cancer in the older person.
- Pilot testing of the computerized cognitive test Microcog in chemotherapy-treated older Cancer patients.
- The abbreviated comprehensive geriatric assessment (aCGA): a retrospective Analysis.
- Decision analysis for Cancer prevention and Cancer treatment in the elderly.
- Biological basis of the association of Cancer and aging comorbidity.
- Biological screening and impact in elderly Cancer patients.
- Never too old? Age should not be a barrier to enrollment in Cancer clinical trials.
- MAX2--a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials.
- Management issues for elderly patients with breast Cancer.
- A comprehensive geriatric intervention detects multiple problems in older breast Cancer patients.
- Studies of comprehensive geriatric assessment in patients with Cancer.
- Optimizing Cancer care in the elderly: progress in geriatric oncology.
- Are older French patients as willing as older American patients to undertake chemotherapy?
- Paclitaxel pharmacokinetics, threshold models, and dosing strategies.
- Comprehensive geriatric assessment basics for the Cancer professional.
- Can older Cancer patients tolerate chemotherapy? A prospective pilot study.
- Indoleamine 2,3-dioxygenase contributes to tumor Cell evasion of T Cell-mediated rejection.
- Predictors of tolerance to chemotherapy in older Cancer patients: a prospective pilot study.
- Comorbidity and geriatric assessment in the elderly patient over the age of 70.
- Phase I trial of a B7-1 (CD80) gene modified autologous tumor Cell vaccine in combination with systemic interleukin-2 in patients with metastatic renal Cell carcinoma.
- Validity and reliability of the FACT-G scale for use in the older person with Cancer.
- Management of breast Cancer in the older woman.
- A practical approach to the older patient with Cancer.
- Challenges in geriatric oncology.
- Evaluation of the elderly with Cancer.
- Measurement and impact of comorbidity in older Cancer patients.
- Management of Cancer in the older person: a practical approach.
- Screening mammography in elderly women. Research on Breast Cancer in Older Women Consortium.
- What threshold for adjuvant therapy in older breast Cancer patients?
- Management of the frail person with advanced Cancer.
- Measuring comorbidity in older Cancer patients.
- Assessment of the older Cancer patient.
- Cancer and aging. An evolving panorama.
- Relationship between cleaved L-selectin levels and the outcome of Acute myeloid leukemia.
- Immunologic nonresponsiveness to tumors.
- Comorbidity and functional status are independent in older Cancer patients.
- Should adjuvant chemotherapy be used to treat breast Cancer in elderly patients (> or = 70 years of age)?
- Cancer chemotherapy in the older patient: what the medical oncologist needs to know.
- Acute leukemia in the elderly.
- Familial primary gastric Lymphoma.
- Empirical antibiotic treatment of sepsis in non-neutropenic patients: single agent or combination therapy?
- Transfusion-associated Graft-versus-host disease in a patient treated with Cladribine (2-chlorodeoxyadenosine): demonstration of exogenous DNA in various tissue extrac...
- Radiation recall in a patient with breast Cancer treated for tuberculosis.
- Initial treatment of sepsis in non-neutropenic patients: ceftazidime alone versus ''best guess'' combined antibiotic therapy.
Schools
University Of Geneva SwitzerlandMd
Hospital Cantonal De Fribourg and University Hospital Geneva Internal Medicine
University Of South Florida College Of Medicine
PHD University Hospital Geneva 1993Medicine
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Oncology
Accepted Insurances
Hospital
-
H. Lee Moffitt Cancer Center and Research Institute -
Tampa General Hospital
Drug Facts
| NPI NUMBER | 1154353589 | |
| NPPES Provider LastName | EXTERMANN | |
| NPPES Provider FirstName | MARTINE | |
| NPPES Provider ZIPCode | 336129416 | |
| NPPES Provider State | FL | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 521.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 34.0 | |
| Percent Opioid Claims | 6.53 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1154353589 |
| Last Name Of The Provider | EXTERMANN |
| First Name Of The Provider | MARTINE |
| View All |
Similar Doctors
|
Dr. Joyson J. Karakunnel, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Eric B. Haura, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Brian C. Betts, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin Creelan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jhanelle Gray, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Amit Mahipal, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Julie A. Kish, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Shilpa Gupta, MD |